Interferons: current status and future directions of this prototypic biological.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000639:trends; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000302:isolation & purification / Q000627:therapeutic use; D007371:Interferon-gamma / Q000302:isolation & purification; D007372:Interferons / Q000502:physiology / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000187:drug effects; D007943:Leukemia, Hairy Cell / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008970:Molecular Weight; D011994:Recombinant Proteins / Q000302:isolation & purification; D012514:Sarcoma, Kaposi / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma; D007372:Interferons